Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Class A Common Stock, $0.01 par value per share
-
Shares outstanding
-
42M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
26M
-
Shares change
-
-493K
-
Total reported value, excl. options
-
$112M
-
Value change
-
-$10.2M
-
Number of buys
-
20
-
Number of sells
-
-33
-
Price
-
$4.30
Significant Holders of RAPID MICRO BIOSYSTEMS, INC. - Class A Common Stock, $0.01 par value per share (RPID) as of Q2 2022
64 filings reported holding RPID - RAPID MICRO BIOSYSTEMS, INC. - Class A Common Stock, $0.01 par value per share as of Q2 2022.
RAPID MICRO BIOSYSTEMS, INC. - Class A Common Stock, $0.01 par value per share (RPID) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26M shares
of 42M outstanding shares and own 61.85% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (8.43M shares), KENNEDY LEWIS MANAGEMENT LP (4.94M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.43M shares), JPMORGAN CHASE & CO (1.48M shares), BlackRock Inc. (1.04M shares), ABG-WTT Global Life Science Capital Partners GP Ltd (1.04M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (750K shares), GLENVIEW CAPITAL MANAGEMENT, LLC (750K shares), Ally Bridge Group (NY) LLC (700K shares), and VANGUARD GROUP INC (680K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.